Motoki Watanabe

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer.

|Mar 25, 2026
Hypoxia and aspirin additively increase intracellular glutamine accumulation in PIK3CA-mutated colorectal cancer cells.

Nodoka Umezaki, Shogen Boku, Yoshiyuki Matsuo

|Jan 30, 2023
A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5.

Motoki Watanabe, Shogen Boku, Kaito Kobayashi

|Jun 24, 2022
Citrus limonL.-Derived Nanovesicles Show an Inhibitory Effect on Cell Growth in p53-Inactivated Colorectal Cancer Cells via the Macropinocytosis Pathway.

Hideki Takakura, Toshimasa Nakao, Takumi Narita

Pageof 1

Frequent Collaborators

3 joint publications

Shogen Boku

2 joint publications

Tomoshi Kameda

2 joint publications

Yoshiyuki Matsuo

2 joint publications

Hironaga Satake